Product Information
OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Lannett Company Inc., priced at $0.0575 per EA under NDC 00527242532. Its NADAC has been published 206 times since Oct 26, 2022.
FDA first approved this application on Feb 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Lannett Company Inc.NDC
00527242532
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA211049FDA Approved
2/22/2019
TE Code
AB
On Market Since
3/5/2019
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 206 times since Oct 26, 2022, and over the history we have for it it has declined 17.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0575 per EA |
|---|---|
| All-time high | $0.0844 (Sep 11, 2024) |
| All-time low | $0.0551 (Aug 19, 2026) |
| 52-week high | $0.0593 |
| 52-week low | $0.0551 |
| Median price | $0.0627 |
| Average price | $0.0636 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 206 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olmesartan medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Lannett Company Inc., is $0.0575 per EA (NDC 00527242532), effective Sep 30, 2026.
How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has declined 17.3%. It has been tracked across 206 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?
Since Oct 26, 2022, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Aug 19, 2026) to a high of $0.0844 (Sep 11, 2024), with a median of $0.0627 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?
OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 00527242532) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.